KYN-101

• Description:

  KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity. KYN-101 decreases CYP1A1 mRNA expression and can be used in the study of breast cancer and acute myeloid leukemia. KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  386.43

• Molecular Formula:

  C22H19FN6

• Notes:

  Research use only, not for human use.

• Receptor:

  AhR

• CAS Number:

  2247950-73-6